The Validity of the Evaluation of Renal Artery Duplex in Critically Ill Acute Kidney Injury Patients

NCT ID: NCT07073508

Last Updated: 2025-07-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-05-01

Study Completion Date

2026-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to assess the clinical relevance of renal artery duplex ultrasound in critically ill patients with acute kidney injury (AKI) in terms of the renal resistive index (RRI).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Diagnosis of acute kidney injury (AKI) is based on rising creatinine as late phenomenon. Intrarenal vasoconstriction occurs earlier, so measuring flow resistance in the renal circulation, renal resistive index (RRI), could become part of vital organ function assessment using Doppler ultrasound.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Validity Renal Artery Duplex Critically Ill Acute Kidney Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Study group

Patients diagnosed with acute kidney injury (AKI).

Renal Artery Duplex

Intervention Type OTHER

Renal artery duplex will be performed to all patients in terms of renal resistivity index (RRI).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Renal Artery Duplex

Renal artery duplex will be performed to all patients in terms of renal resistivity index (RRI).

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients age \>18 years.
* Both sexes.
* Patients within 24 hours after intensive care unit (ICU) admission.

Exclusion Criteria

* Patients presented with poor abdominal echogenicity.
* Chronic kidney disease, especially with estimated creatinine clearance less than 30 ml/min/1.73m.
* Patients with dialysis dependency.
* Patients with renal transplantation.
* Patients with known renal artery stenosis.
* If there is a pregnancy.
* Patients with any congenital kidney diseases as mono-kidney, anatomic kidney abnormalities.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ain Shams University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mahmoud rabie

Assistant Lecturer of Anesthesiology, Intensive Care and Pain Management, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ain Shams University

Cairo, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mahmoud R Basiony, Master

Role: CONTACT

00201094726393

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mahmoud R Basiony, Master

Role: primary

00201094726393

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FMASU MD51/2024

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.